WO2007017127A3 - Controlled realease dosage form of pirazole compounds to treat urinary incontinence - Google Patents

Controlled realease dosage form of pirazole compounds to treat urinary incontinence Download PDF

Info

Publication number
WO2007017127A3
WO2007017127A3 PCT/EP2006/007420 EP2006007420W WO2007017127A3 WO 2007017127 A3 WO2007017127 A3 WO 2007017127A3 EP 2006007420 W EP2006007420 W EP 2006007420W WO 2007017127 A3 WO2007017127 A3 WO 2007017127A3
Authority
WO
WIPO (PCT)
Prior art keywords
urinary incontinence
dosage form
treat urinary
pirazole
compounds
Prior art date
Application number
PCT/EP2006/007420
Other languages
French (fr)
Other versions
WO2007017127A2 (en
Inventor
Xavier Lizcano
Original Assignee
Esteve Labor Dr
Xavier Lizcano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr, Xavier Lizcano filed Critical Esteve Labor Dr
Publication of WO2007017127A2 publication Critical patent/WO2007017127A2/en
Publication of WO2007017127A3 publication Critical patent/WO2007017127A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention refers to a pharmaceutical composition for oral administration of pirazole compounds for the treatment of urinary incontinence.
PCT/EP2006/007420 2005-07-29 2006-07-27 Controlled realease dosage form of pirazole compounds to treat urinary incontinence WO2007017127A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05384034 2005-07-29
EP05384034.4 2005-07-29

Publications (2)

Publication Number Publication Date
WO2007017127A2 WO2007017127A2 (en) 2007-02-15
WO2007017127A3 true WO2007017127A3 (en) 2007-04-19

Family

ID=35529648

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/007420 WO2007017127A2 (en) 2005-07-29 2006-07-27 Controlled realease dosage form of pirazole compounds to treat urinary incontinence

Country Status (2)

Country Link
ES (1) ES2334548B1 (en)
WO (1) WO2007017127A2 (en)

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1413305A1 (en) * 2001-07-06 2004-04-28 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
WO2005097099A1 (en) * 2004-04-05 2005-10-20 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol combined to at least an nsaid
WO2005097192A2 (en) * 2004-04-05 2005-10-20 Laboratorios Del Dr. Esteve, S.A. Active substance combination of a carbinol compound and an opioid
WO2006010627A1 (en) * 2004-07-30 2006-02-02 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbinols
WO2006027221A1 (en) * 2004-09-07 2006-03-16 Laboratorios Del Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction
WO2006027226A1 (en) * 2004-09-07 2006-03-16 Laboratorios Del Dr. Esteve S.A. Derivatives of aryl(or heteroaryl) azolylcarbinols for the treatment of central neuropathic pain
EP1671968A1 (en) * 2004-12-17 2006-06-21 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
WO2006063860A2 (en) * 2004-12-17 2006-06-22 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1674465A1 (en) * 2004-12-27 2006-06-28 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
WO2006069767A1 (en) * 2004-12-27 2006-07-06 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1690537A1 (en) * 2005-02-15 2006-08-16 Laboratorios Del Dr. Esteve, S.A. Derivatives of aryl(or heteroaryl) azolycarbinols for the treatment of fibromyalgia
WO2006087147A2 (en) * 2005-02-15 2006-08-24 Laboratorios Del Dr. Esteve, S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of fibromyalgia
EP1695704A1 (en) * 2005-02-28 2006-08-30 Laboratorios Del Dr. Esteve, S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of fibromyalgia

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1413305A1 (en) * 2001-07-06 2004-04-28 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
WO2005097099A1 (en) * 2004-04-05 2005-10-20 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol combined to at least an nsaid
WO2005097192A2 (en) * 2004-04-05 2005-10-20 Laboratorios Del Dr. Esteve, S.A. Active substance combination of a carbinol compound and an opioid
WO2006010627A1 (en) * 2004-07-30 2006-02-02 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbinols
WO2006027221A1 (en) * 2004-09-07 2006-03-16 Laboratorios Del Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction
WO2006027226A1 (en) * 2004-09-07 2006-03-16 Laboratorios Del Dr. Esteve S.A. Derivatives of aryl(or heteroaryl) azolylcarbinols for the treatment of central neuropathic pain
EP1671968A1 (en) * 2004-12-17 2006-06-21 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
WO2006063860A2 (en) * 2004-12-17 2006-06-22 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1674465A1 (en) * 2004-12-27 2006-06-28 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
WO2006069767A1 (en) * 2004-12-27 2006-07-06 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1690537A1 (en) * 2005-02-15 2006-08-16 Laboratorios Del Dr. Esteve, S.A. Derivatives of aryl(or heteroaryl) azolycarbinols for the treatment of fibromyalgia
WO2006087147A2 (en) * 2005-02-15 2006-08-24 Laboratorios Del Dr. Esteve, S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of fibromyalgia
EP1695704A1 (en) * 2005-02-28 2006-08-30 Laboratorios Del Dr. Esteve, S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of fibromyalgia

Also Published As

Publication number Publication date
WO2007017127A2 (en) 2007-02-15
ES2334548A1 (en) 2010-03-11
ES2334548B1 (en) 2010-10-27

Similar Documents

Publication Publication Date Title
WO2007087468A3 (en) Adiponectin for treatment of various disorders
WO2009016410A3 (en) Chemical compounds 831
WO2007128802A3 (en) Use of flibanserin for the treatment of post-menopausal sexual desire disorders
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
WO2007025613A3 (en) Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain
WO2008064107A3 (en) 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods
WO2007048801A3 (en) Sexual desire enhancing medicaments comprising benzimidazolone derivatives
MX2011012122A (en) Thiophene derivatives.
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
WO2005115470A3 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING β-CARBOLINE DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF CANCER
WO2009153665A3 (en) Inhibitors of the shiga toxins trafficking through the retrograde pathway
WO2007093183A3 (en) Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
WO2008097924A3 (en) Pharmaceutical compositions comprising dextromethorphan analogs for the treatment of neurological disorders
WO2007121088A3 (en) Combinations of therapeutic agents for treating cancer
WO2008020027A3 (en) 2,5-dihydroxybenzene compounds for the treatment of skin cancer
WO2006081431A3 (en) Compounds for treating inflammatory and demyelinating diseases
IL193252A0 (en) N-hydroxyacrylamide compounds
WO2008052139A3 (en) Ultra low dose doxepin and methods of using the same to treat sleep disorders
IL192415A0 (en) Pharmaceutical composition for the treatment of nail diseases
WO2007136741A3 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
IL179337A0 (en) Pharmaceutical compositions for the treatment of pruritus
WO2006113718A3 (en) Compositions for the treatment of neoplasms
WO2006079077A3 (en) Use of diltiazem or analogs thereof as modulators of ghrelin receptor
WO2005112923A3 (en) 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 200850024

Country of ref document: ES

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06776443

Country of ref document: EP

Kind code of ref document: A2

WWP Wipo information: published in national office

Ref document number: 200850024

Country of ref document: ES

Kind code of ref document: A

WWG Wipo information: grant in national office

Ref document number: 200850024

Country of ref document: ES

Kind code of ref document: A